Yuqin Cao

Ruijin Hospital, Shanghai Jiao Tong University

Papers

6

Total Citations

242

H-Index

5

About

Yuqin Cao is a leading thoracic surgeon and researcher whose work is redefining the landscape of minimally invasive surgery for thoracic cancers. Her primary research focuses on comparing robotic-assisted techniques with conventional video-assisted approaches for lung cancer and esophageal cancer. Cao’s major contributions include leading the landmark RVlob randomized controlled trial, which provided the first high-level evidence that robotic-assisted lobectomy offers comparable long-term survival and perioperative outcomes to video-assisted lobectomy for non-small-cell lung cancer. Her work has been cited over 240 times, with her 2021 study on robotic-assisted versus video-assisted thoracoscopic lobectomy alone garnering 116 citations. She has also advanced the field of esophageal cancer surgery, demonstrating the safety and efficacy of robot-assisted Ivor Lewis esophagectomy. Notably, her 2023 study on health-related quality of life after robotic-assisted lobectomy provides crucial patient-centered outcomes data. Through rigorous clinical trials and systematic reviews, Cao is helping to establish robotic surgery as a standard of care, improving recovery and outcomes for patients worldwide.

Research Focus

Key Achievements

5
H-Index
6
Papers
242
Total Citations
40
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted Versus Video-assisted Thoracoscopic Lobectomy
116 citations · 2021
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 45
🏛 Institutions: Ruijin Hospital, Shanghai Jiao Tong University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago